EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study

Andrew R Thompson iD, Christos Tziotzios iD, John Nesnas, Rowena Randall, Maciej Czachorowski, Andrew G Messenger iD

British Journal of Dermatology · 18.11.2024 · 191 (6) · 924-935

DOI: 10.1093/bjd/ljae307 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Dermatology, online erschienen am 06.08.2024. Verfasst von Andrew R Thompson und 5 weiteren Autor:innen. Beteiligte Einrichtung: South Wales Clinical Psychology Training Programme, Department of Psychology, Cardiff University, Tower Building, Cardiff, Wales. Hauptthemen laut MEDLINE: Alopecia Areata, Healthcare Disparities. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alopecia areata (AA) is an immune-mediated form of hair loss that can occur at any age, often with a significant mental health burden.

Objectives

We aimed to provide estimates of the lifetime incidence of AA, and the impacts on mental health, healthcare utilization and work-related outcomes, assessing variation across major sociodemographic subgroups.

Methods

AA cases were identified in primary care from the UK population-based Oxford-Royal College of General Practitioners Research and Surveillance Centre database (2009–2018). Lifetime incidence of AA was estimated at age 80 years using modified time-to-event models with age as the timescale, overall and stratified by sex, ethnicity, deprivation and geography. Mental health, healthcare utilization and work-related outcomes were assessed in the 2 years after AA diagnosis compared with matched unaffected controls, and stratified by the same sociodemographic subgroups.

Results

During the study period, 6961 people developed AA. Overall lifetime incidence of AA was 2.11% [95% confidence interval (CI) 2.06–2.16]. Females had a higher lifetime incidence (2.35%, 95% CI 2.28–2.43) than males (1.88%, 95% CI 1.81–1.94). Lifetime incidence was higher in those of Asian ethnicity (5.87%, 95% CI 5.51–6.24), Other (4.5%, 95% CI 3.63–5.31), Mixed (4.4%, 95% CI 3.50–5.37) and Black (3.0%, 95% CI 2.63–3.42) ethnicity, compared with White ethnicity (1.7%, 95% CI 1.68–1.80). Lifetime incidence was highest in those with the greatest deprivation: most-deprived quintile (2.92%, 95% CI 2.77–3.07) compared with least-deprived (1.68%, 95% CI 1.59–1.78). Across sociodemographic subgroups, people with AA of Black ethnicity were most likely to have anxiety (adjusted odds ratio vs. matched controls 2.92, 95% CI 1.71–4.91), and had the greatest risk of time off work (adjusted hazard ratio vs. matched controls 2.54, 95% CI 1.80–3.56).

Conclusions

AA affects around 1 in 50 people over their lifetime. The incidence and impact of AA on mental health and work outcomes is highest in ethnic groups other than White. Clinicians should be aware of the marked heterogeneity in the incidence and impact of AA, and support targeted healthcare to groups at the highest risk of alopecia and its consequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataHealthcare DisparitiesHumansMaleFemaleIncidenceUnited KingdomMiddle AgedAdultAgedYoung AdultAdolescentAged, 80 and overChildChild, PreschoolPatient Acceptance of Health CareCohort Studies

Autor:innen und Institutionen

  • South Wales Clinical Psychology Training Programme, Department of Psychology, Cardiff University, Tower Building, Cardiff, Wales.
  • St John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, UK.
  • Pfizer Ltd, Walton Oaks, Walton on the Hill, Tadworth, Surrey, UK.
  • University of Sheffield, Sheffield, UK.

ORCID-Profile: Andrew R Thompson, Christos Tziotzios, Andrew G Messenger

Förderung

  • Pfizer

Zitieren

APA

Thompson, A. R., Tziotzios, C., Nesnas, J., Randall, R., Czachorowski, M., & Messenger, A. G. (2024). Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study. British Journal of Dermatology, 191(6), 924-935. https://doi.org/10.1093/bjd/ljae307

Vancouver

Thompson AR, Tziotzios C, Nesnas J, Randall R, Czachorowski M, Messenger AG. Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study. British Journal of Dermatology. 2024;191(6):924-935. doi:10.1093/bjd/ljae307

BibTeX
@article{Thompson2024,
  author = {Thompson, Andrew R and Tziotzios, Christos and Nesnas, John and Randall, Rowena and Czachorowski, Maciej and Messenger, Andrew G},
  title = {Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study},
  journal = {British Journal of Dermatology},
  year = {2024},
  volume = {191},
  number = {6},
  pages = {924--935},
  doi = {10.1093/bjd/ljae307}
}
Kostenlos starten →